Rare Kidney Diseases Market (4th edition): Distribution by Target Indication, Type of Molecule (Small Molecules and Biologics), Type of Biologic (Monoclonal Antibodies, Enzymes, Proteins / Peptides, Hormones and Cell and Gene Therapies), Route of Administration, Type of Therapy (Monotherapies and Combination Therapies), Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa), and Leading Drug Developers- Trends and Forecast 2026-2040